Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%

Published April 2, 2014

Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%
DUBLIN and LAVAL, Quebec, March 25, 2014 /PRNewswire/ — Actavis plc (NYSE:ACT) and Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TOR:CA:VRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug …
Read more on MarketWatch

Drug Rehab – Alcohol Addiction Treatment Center — World Class Drug & Alcohol Rehab Centers. 24 Hour Free Helpline 1-866-569-7073.

More Drug And Alcohol Treatment Centers In Quebec Information…